Bush T L, Riedel D
Department of Epidemiology, School of Hygiene and Public Health, Johns Hopkins University, Baltimore, Md 21205.
Circulation. 1991 Apr;83(4):1287-93. doi: 10.1161/01.cir.83.4.1287.
The National Cholesterol Education Program (NCEP) has provided guidelines for identification of persons at high risk of coronary heart disease (CHD) because of lipid abnormalities. These recommendations are based on total cholesterol as the initial screening tool and have become the stimulus for clinic- and community-based screening programs nationwide. However, the use of the guidelines may be problematic because individuals may have total cholesterol levels in the desirable range but low density lipoprotein (LDL) or high density lipoprotein (HDL) levels considered at high risk. This study evaluates the ability of the NCEP screening recommendations to identify correctly persons at high risk of CHD because of lipid abnormalities.
Using the NCEP guidelines, we simulated a population-based screening program with data from visits 1 and 2 of the Lipid Research Clinics Program Prevalence Study. Individuals were considered to be at high risk of CHD if they had LDL levels greater than 160 mg/dl or HDL levels less than 35 mg/dl. Following the NCEP process, 21% of those with high LDL concentrations and 66% of those with low HDL concentrations would not be routinely referred for immediate treatment. Overall, 41% of those at high risk of CHD would not be promptly evaluated. The sensitivity of the guidelines for promptly identifying individuals with lipoprotein abnormalities is 59%.
This relatively low sensitivity of total cholesterol as a screening tool should be the impetus for rethinking the screening guidelines. Specifically, the cost-benefit ratio of routine screening for lipoproteins, particularly HDL cholesterol, needs to be carefully considered.
国家胆固醇教育计划(NCEP)已发布指南,用于识别因脂质异常而患冠心病(CHD)高危人群。这些建议以总胆固醇作为初始筛查工具,已成为全国范围内基于诊所和社区的筛查计划的推动力。然而,使用这些指南可能存在问题,因为个体的总胆固醇水平可能处于理想范围,但低密度脂蛋白(LDL)或高密度脂蛋白(HDL)水平却被视为高危。本研究评估了NCEP筛查建议正确识别因脂质异常而患CHD高危人群的能力。
使用NCEP指南,我们利用脂质研究诊所项目患病率研究第1次和第2次访视的数据模拟了一项基于人群的筛查计划。如果个体的LDL水平高于160mg/dl或HDL水平低于35mg/dl,则被视为患CHD高危人群。按照NCEP流程,LDL浓度高的人群中有21%以及HDL浓度低的人群中有66%不会被常规转诊接受立即治疗。总体而言,41%的CHD高危人群不会得到及时评估。指南迅速识别脂蛋白异常个体的敏感性为59%。
总胆固醇作为筛查工具的这种相对较低的敏感性应促使人们重新思考筛查指南。具体而言,需要仔细考虑脂蛋白常规筛查,尤其是HDL胆固醇筛查的成本效益比。